Caris Life Sciences MI GPS Score

Caris Life Sciences has launched the MI GPS (Genomic Profiling Similarity) Score, an AI-driven tumor type biology similarity score that uses more than 6,500 mathematical models in the machine learning algorithm to compare molecular characteristics of a patient's tumor against Caris' extensive database. The results are intended to provide new insights into the molecular subtype of cancer of unknown primary (CUP) cases, atypical clinical presentation cases, and other difficult-to-treat cancer cases to help guide treatment decisions, the company said.